Globus Medical, Inc.
Financials
Valuation Metrics
Globus Medical, Inc.'s Market Cap is $11.06B. At end of 2025 it was $11.80B. Ranked #906 of 3,111 in US market (top 29%), #621 of 1,666 on NYSE (top 37%), #59 of 206 in Health Care Equipment & Services (top 29%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $11.06B | US#906/3,111 Sec#59/206 |
| Revenue | $3.10B | US#1,206/3,111 Sec#72/206 |
| Net Income | $587M | US#735/3,111 Sec#42/206 |
| Total Assets | $5.44B | US#1,388/3,111 Sec#67/206 |
| Net Assets | $4.73B | US#729/3,111 Sec#41/206 |
| Employees | 6,000 | US#769/3,111 Sec#69/206 |
| Value | ||
| P/E | 18.85x | US#910/3,111 Sec#20/206 |
| P/B | 2.34x | US#1,358/3,111 Sec#76/206 |
| PEG | 0.29x | US#389/3,111 Sec#12/206 |
| P/S | 3.57x | US#1,940/3,111 Sec#136/206 |
| EV/EBITDA | 12.06x | US#1,027/3,111 Sec#34/206 |
| FCF Yield | 5.43% | US#1,176/3,111 Sec#57/206 |
| Profitability | ||
| ROE | 12.40% | US#1,078/3,111 Sec#48/206 |
| ROA | 10.79% | US#398/3,111 Sec#22/206 |
| Op. Margin | 17.62% | US#1,070/3,111 Sec#35/206 |
| Revenue Growth | 27.04% | US#548/3,111 Sec#34/206 |
| Earnings Growth | 64.72% | US#474/3,111 Sec#18/206 |
| Financial Health | ||
| Debt Ratio | 14.95% | US#176/3,111 Sec#13/206 |
| Total Debt | $115M | US#2,377/3,111 Sec#133/206 |
| FCF | $600M | US#790/3,111 Sec#48/206 |
| Cash | $561M | US#998/3,111 Sec#54/206 |
| Current Ratio | 4.56x | US#531/3,111 Sec#50/206 |
| Net Debt/EBITDA | -0.51x | US#444/3,111 Sec#29/206 |
| Performance | ||
| 1Y Return | 54.75% | US#720/3,111 Sec#53/206 |
| 1M Return | 1.67% | US#1,018/3,111 Sec#83/206 |
| From 52W High | -19.66% | US#1,769/3,111 Sec#119/206 |
| 1Y MDD | -22.10% | US#1,169/3,111 Sec#37/206 |
| Trading | ||
| Volume | 743,669 shares | US#1,585/3,111 Sec#101/206 |
| Trading Value | $60M | US#1,142/3,111 Sec#76/206 |
| Per Share | ||
| EPS | $3.98 | US#782/3,111 Sec#46/206 |
| BPS | $33.84 | US#754/3,111 Sec#49/206 |
Company Info
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.